VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,096,800 | +5.4% | 85,479 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,989,096 | -8.1% | 85,479 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $2,163,473 | +20.3% | 85,479 | -8.3% | 0.01% | +14.3% |
| Q3 2022 | $1,798,000 | -24.3% | 93,256 | 0.0% | 0.01% | -22.2% |
| Q2 2022 | $2,375,000 | +7.7% | 93,256 | +8.7% | 0.01% | +28.6% |
| Q1 2022 | $2,206,000 | -38.6% | 85,760 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $3,591,000 | +41.4% | 85,760 | +47.0% | 0.01% | +25.0% |
| Q3 2021 | $2,539,000 | -4.6% | 58,339 | +3.6% | 0.01% | -11.1% |
| Q2 2021 | $2,661,000 | – | 56,290 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |